vs
Side-by-side financial comparison of Marygold Companies, Inc. (MGLD) and MAXCYTE, INC. (MXCT). Click either name above to swap in a different company.
Marygold Companies, Inc. is the larger business by last-quarter revenue ($7.6M vs $4.8M, roughly 1.6× MAXCYTE, INC.). Marygold Companies, Inc. runs the higher net margin — -7.5% vs -200.5%, a 192.9% gap on every dollar of revenue. On growth, Marygold Companies, Inc. posted the faster year-over-year revenue change (-4.5% vs -20.9%). Over the past eight quarters, Marygold Companies, Inc.'s revenue compounded faster (-1.5% CAGR vs -7.4%).
Marygold Companies, Inc. is a U.S.-headquartered diversified holding company that operates across three core segments: financial services, specialty manufacturing, and consumer goods. It primarily caters to North American markets, driving long-term value growth via strategic investment in, and operational optimization of, its portfolio of subsidiary entities.
MaxCyte Inc. is a global biotechnology company focused on developing cell engineering platforms and enabling technologies for cell and gene therapy advancement. Its proprietary non-viral cell modification systems are widely used by pharmaceutical, biotech and life science research entities to develop immunotherapies, gene-edited treatments and next-generation biologic drugs from preclinical research through commercialization.
MGLD vs MXCT — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.6M | $4.8M |
| Net Profit | $-576.0K | $-9.6M |
| Gross Margin | 74.0% | — |
| Operating Margin | -8.3% | -234.5% |
| Net Margin | -7.5% | -200.5% |
| Revenue YoY | -4.5% | -20.9% |
| Net Profit YoY | 67.0% | 9.4% |
| EPS (diluted) | $-0.01 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.6M | $4.8M | ||
| Q3 25 | $7.0M | $4.6M | ||
| Q2 25 | $7.2M | $5.8M | ||
| Q1 25 | $7.0M | $5.7M | ||
| Q4 24 | $8.0M | $6.1M | ||
| Q3 24 | $7.9M | $5.6M | ||
| Q2 24 | $8.3M | $5.0M | ||
| Q1 24 | $7.9M | $5.6M |
| Q4 25 | $-576.0K | $-9.6M | ||
| Q3 25 | $-356.0K | $-12.4M | ||
| Q2 25 | $-1.5M | $-12.4M | ||
| Q1 25 | $-1.0M | $-10.3M | ||
| Q4 24 | $-1.7M | $-10.6M | ||
| Q3 24 | $-1.6M | $-11.6M | ||
| Q2 24 | $-1.9M | $-9.4M | ||
| Q1 24 | $-529.0K | $-9.5M |
| Q4 25 | 74.0% | — | ||
| Q3 25 | 77.0% | — | ||
| Q2 25 | 67.8% | — | ||
| Q1 25 | 75.0% | — | ||
| Q4 24 | 74.1% | — | ||
| Q3 24 | 73.1% | — | ||
| Q2 24 | 72.5% | — | ||
| Q1 24 | 70.5% | — |
| Q4 25 | -8.3% | -234.5% | ||
| Q3 25 | -18.2% | -307.4% | ||
| Q2 25 | -16.5% | -244.3% | ||
| Q1 25 | -21.4% | -214.1% | ||
| Q4 24 | -22.8% | -213.1% | ||
| Q3 24 | -27.4% | -250.4% | ||
| Q2 24 | -33.3% | -241.0% | ||
| Q1 24 | -18.7% | -219.8% |
| Q4 25 | -7.5% | -200.5% | ||
| Q3 25 | -5.1% | -269.7% | ||
| Q2 25 | -20.4% | -212.2% | ||
| Q1 25 | -14.4% | -178.7% | ||
| Q4 24 | -21.8% | -175.0% | ||
| Q3 24 | -20.1% | -205.9% | ||
| Q2 24 | -22.5% | -188.8% | ||
| Q1 24 | -6.7% | -170.6% |
| Q4 25 | $-0.01 | — | ||
| Q3 25 | $-0.01 | $-0.12 | ||
| Q2 25 | $-0.04 | $-0.12 | ||
| Q1 25 | $-0.02 | — | ||
| Q4 24 | $-0.04 | — | ||
| Q3 24 | $-0.04 | $-0.11 | ||
| Q2 24 | $-0.05 | $-0.09 | ||
| Q1 24 | $-0.01 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.6M | $103.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $22.7M | $171.5M |
| Total Assets | $27.8M | $202.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.6M | $103.0M | ||
| Q3 25 | $12.5M | $105.7M | ||
| Q2 25 | $12.8M | $126.6M | ||
| Q1 25 | $15.6M | $138.3M | ||
| Q4 24 | $14.9M | $154.5M | ||
| Q3 24 | $17.5M | $153.8M | ||
| Q2 24 | $15.0M | $157.3M | ||
| Q1 24 | $16.1M | $157.5M |
| Q4 25 | $22.7M | $171.5M | ||
| Q3 25 | $22.9M | $180.3M | ||
| Q2 25 | $23.0M | $190.7M | ||
| Q1 25 | $24.3M | $199.4M | ||
| Q4 24 | $23.4M | $206.3M | ||
| Q3 24 | $25.5M | $213.3M | ||
| Q2 24 | $26.6M | $221.3M | ||
| Q1 24 | $28.4M | $226.4M |
| Q4 25 | $27.8M | $202.5M | ||
| Q3 25 | $28.4M | $213.5M | ||
| Q2 25 | $30.4M | $219.8M | ||
| Q1 25 | $33.5M | $230.0M | ||
| Q4 24 | $33.0M | $239.5M | ||
| Q3 24 | $35.9M | $248.6M | ||
| Q2 24 | $32.9M | $251.5M | ||
| Q1 24 | $33.7M | $257.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-908.0K | $-2.7M |
| Free Cash FlowOCF − Capex | — | $-2.9M |
| FCF MarginFCF / Revenue | — | -61.0% |
| Capex IntensityCapex / Revenue | 0.0% | 4.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-36.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-908.0K | $-2.7M | ||
| Q3 25 | $-533.0K | $-7.5M | ||
| Q2 25 | $-3.3M | $-9.9M | ||
| Q1 25 | $-1.2M | $-14.4M | ||
| Q4 24 | $-770.0K | $-7.8M | ||
| Q3 24 | $-893.0K | $-4.4M | ||
| Q2 24 | $-1.9M | $-4.8M | ||
| Q1 24 | $-658.0K | $-10.6M |
| Q4 25 | — | $-2.9M | ||
| Q3 25 | $-562.0K | $-7.8M | ||
| Q2 25 | $-3.4M | $-10.4M | ||
| Q1 25 | — | $-15.1M | ||
| Q4 24 | $-776.0K | $-8.0M | ||
| Q3 24 | $-940.0K | $-4.8M | ||
| Q2 24 | $-2.0M | $-5.1M | ||
| Q1 24 | — | $-11.4M |
| Q4 25 | — | -61.0% | ||
| Q3 25 | -8.1% | -168.5% | ||
| Q2 25 | -46.8% | -179.2% | ||
| Q1 25 | — | -262.3% | ||
| Q4 24 | -9.7% | -131.6% | ||
| Q3 24 | -11.9% | -85.5% | ||
| Q2 24 | -23.8% | -103.3% | ||
| Q1 24 | — | -203.6% |
| Q4 25 | 0.0% | 4.8% | ||
| Q3 25 | 0.4% | 6.5% | ||
| Q2 25 | 0.7% | 10.0% | ||
| Q1 25 | 0.0% | 11.4% | ||
| Q4 24 | 0.1% | 2.4% | ||
| Q3 24 | 0.6% | 7.2% | ||
| Q2 24 | 0.7% | 5.9% | ||
| Q1 24 | 0.0% | 14.4% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MGLD
| Fund Management Related Party | $4.6M | 60% |
| Food Products | $1.7M | 22% |
| Beauty Products | $1.2M | 15% |
| Other | $268.0K | 4% |
MXCT
| Products | $4.2M | 87% |
| Other | $634.0K | 13% |
